about
Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo.An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinomaIdentification and characterization of novel human glioma-specific peptides to potentiate tumor-specific gene delivery.Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model.DEAD-box helicase DP103 defines metastatic potential of human breast cancers.Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathwaysMiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinomaDevelopment of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivoSystemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth.CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinomapH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma.Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signalingMetronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer.Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers.The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma.An Anti-Human Lutheran Glycoprotein Phage Antibody Inhibits Cell Migration on Laminin-511: Epitope Mapping of the AntibodyCarbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma.Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP(5+), Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme.Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinoma.Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expressionMatrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma.pH-Sensitive Pt Nanocluster Assembly Overcomes Cisplatin Resistance and Heterogeneous Stemness of Hepatocellular CarcinomaA novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma.MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.Mechanism of cancer drug resistance and the involvement of noncoding RNAs.A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.Targeting transcription factor STAT3 for cancer prevention and therapy.Re-expression of major histocompatibility complex (MHC) class I molecules on malignant tumor cells and its effect on host-tumor interaction.MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence.Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma.Single-layer MoS2 nanosheet grafted upconversion nanoparticles for near-infrared fluorescence imaging-guided deep tissue cancer phototherapy.EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma.Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.Benzylidene-indolinones are effective as multi-targeted kinase inhibitor therapeutics against hepatocellular carcinoma.Matrix metalloproteinase-1-mediated mesenchymal stem cell tumor tropism is dependent on crosstalk with stromal derived growth factor 1/C-X-C chemokine receptor 4 axis.Preclinical evaluation of transcriptional targeting strategy for human hepatocellular carcinoma in an orthotopic xenograft mouse model.
P50
Q30576918-4691ED3F-D423-4340-8D1A-CA64A2FDE809Q30619662-2447F06E-9900-4CB4-ADDE-3CD847DEB6DAQ33206087-9C41500D-ABB9-4764-9014-9377879CB741Q33688390-91EA3BC2-6958-4493-B453-ABBF818C0D13Q34117601-9BCE9B6F-20F5-4100-9A3C-A7D91CFCCB2DQ34199851-52E1E454-DAA4-4A1A-8206-34B34139705EQ34409807-65082BD8-CD71-4B5A-AF2A-130CF8209BF2Q34614290-A7F4C55E-C0A7-4B2F-B5D5-7F9DEAF8F693Q34634316-F1033C9C-8410-43B1-9D10-35F2E33D45D9Q35073868-03793F6B-0497-4076-BFF6-0BBDDD565705Q35194416-A992EEB8-EB3C-4DA6-B24A-A176BF9CBD97Q35219359-54328BBD-2822-4850-9E03-91997B5BAE56Q35399206-5AA38570-7B65-4F77-9AE4-B3F81D2963DDQ35610404-7B9FA007-23C4-444E-A937-DC67482F5CADQ35741628-51008F28-4830-4D9B-A25B-85A9A2AE0B94Q35742449-291C297D-D0C4-4D6F-8EE4-E65F02B39992Q36242464-CD26C7FF-E112-4CB8-B816-D10121BCA280Q36936884-88C18C6E-4772-4CE9-821A-5DA267D824C2Q37049935-AF9C9422-C6A2-48C1-A141-B819B9A88912Q37226209-110C7318-18AF-4D49-98D5-6E734DD43A30Q37237164-DA8F3A56-1BF8-4DEB-A05B-4EF262C91A2BQ37282599-027FCE93-3FBD-4B26-AB32-3ACE20C887E4Q37395716-81A4BA92-22D6-4656-9057-A5EBA50152D0Q37407113-20D1018E-3FD4-484B-BBBD-8B207749D04AQ37449500-CD1F106D-4BB8-40BA-BC5A-BB428BB0813BQ37706507-53301882-07C9-46BB-A978-F97636F0FD75Q38043263-85FA4F4A-2725-4615-91F1-A42ABFF02379Q38204798-97480578-325A-4EBE-B280-CF6973DB9B08Q38310455-F8B24AC9-53DF-453A-84CA-43DC9C62E138Q38610564-F4C09F15-133F-4906-BB85-A0866B488C4DQ38687276-667FE468-BDFE-449A-AC23-1CAC23DACF93Q38735947-AAC13BA2-52B4-48D3-850F-AD5BE7CFF6A6Q38739240-C36C58E1-E8D2-4D61-8277-684E4B5C15E1Q38781812-141B7E7D-06EF-4C10-B8D8-AB55C3D1FF3DQ38874126-BEAF41E9-5763-4A0C-A0D2-74BE8F2945A0Q38916178-3653A6E2-D3B9-4539-8FEC-66DC1AFAFA00Q38916913-F8EA5BC3-6935-4F5D-9442-F910A656728BQ38993878-5F418A65-2D46-478F-B5BA-5080D33788C4Q39069170-F657B17C-91F2-463E-823B-9B1BA77FF0D1Q39145872-D3D30DD8-C357-4F15-8910-C560ADD361A7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kam M Hui
@ast
Kam M Hui
@en
Kam M Hui
@es
Kam M Hui
@nl
type
label
Kam M Hui
@ast
Kam M Hui
@en
Kam M Hui
@es
Kam M Hui
@nl
prefLabel
Kam M Hui
@ast
Kam M Hui
@en
Kam M Hui
@es
Kam M Hui
@nl
P108
P106
P108
P1153
7103304713
P31
P496
0000-0003-1820-1399